🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

Based on TikTok, the platform has removed violative content and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Digital Trading Activities

Research also discovered communities with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.

Within moments of joining one group, a vendor posted WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Inside these groups, messages show black plastic packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly serious medical dangers”.